A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
暂无分享,去创建一个
J. Yokota | H. Ogiwara | T. Kohno | Y. Tominaga | K. Tsuta | T. Nakano | T. Oike | O. Ando | K. Furuta | Hisanori Isomura | Kentaro Ito | T. Mizukami | Yoko Shimada | Mayumi Komachi | Shun‐ichi Watanabe | Shun-ichi Watanabe | Shun-Ichi Watanabe